Determination of candidal vulvovaginitis prevalence in patients referred to the gynecology clinic of Imam Khomeini Hospital, Noor City, Iran
Candidal vulvovaginitis prevalence in patients
DOI:
https://doi.org/10.22122/cdj.v13i1.651Keywords:
Gynecology, Candida, Polymerase Chain ReactionAbstract
BACKGROUND: Candidal vulvovaginitis is an infection of the female genital tract that is caused by overgrowth of Candida, especially Candida albicans (C. albicans), and it may sometimes be recurrent. This research aimed to determine Candidal vulvovaginitis prevalence in women by phenotypic tests and polymerase chain reaction (PCR).
METHODS: This descriptive cross-sectional study was performed in Noor City, Iran, in 2017, on 36 patients with Candidal vulvovaginitis. Samples were isolated and identified by direct and phenotypic tests. Then, to confirm the isolates, molecular PCR and sequencing were used. Frequency determination was performed for them using SPSS software.
RESULTS: Out of 15 isolates, 10 (66.67%) belonged to the C. albicans species and 5 (33.33%) isolates belonged to Candida glabrata (C. glabrata). PCR-sequencing showed that out of 15 isolates, 10 isolates were positive for C. albicans, and all 5 isolates were C. glabrata.
CONCLUSION: C. albicans and C. glabrata species were the most common cause of Candidal vulvovaginitis. Although C. albicans is still the predominant species in patients with Candidal vulvovaginitis, the increase in non-albicans species is a fact that requires further research by researchers in this field.
References
Jacob L, John M, Kalder M, Kostev K. Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: A retrospective study of 954,186 patients. Curr Med Mycol. 2018; 4(1): 6-11.
Kord Z, Fata A, Zarrinfar H. Molecular Identification of Candida species isolated from patients with vulvovaginitis for the first time in Mashhad. Iran J Obstet Gynecol Infertil. 2017; 20(4): 50-7.
De Oliveira Santos GC, Vasconcelos CC, Lopes AJO, De Sousa Cartágenes MDS, Filho A, Do Nascimento FRF, et al. Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents. Front Microbiol. 2018; 9: 1351.
Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species. Front Microbiol. 2016; 7: 2173.
Mirhendi SH, Makimura K, Shidfar MR, Hossienpour L. Identification and Frequency of Candida Patient Isolates by CHROMagar Candida Method. Avicenna J Clin Med. 2007; 13(4): 11-5.
A ME-G, N EY, H AK. Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt. Curr Med Mycol. 2021; 7(1): 31-7.
Sasani E, Rafat Z, Ashrafi K, Salimi Y, Zandi M, Soltani S, et al. Vulvovaginal candidiasis in Iran: A systematic review and meta-analysis on the epidemiology, clinical manifestations, demographic characteristics, risk factors, etiologic agents and laboratory diagnosis. Microb Pathog. 2021; 154:104802.
Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med. 1998; 13(5): 335-46.
Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel). 2017; 3(4): 57.
Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Yazdani Cherati J, Mosayebi E. Isolation of different species of Candida in patients with vulvovaginal candidiasis from sari, iran. Jundishapur J Microbiol. 2015; 8(4): e15992.
Fidel PL, Jr., Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999; 12(1): 80-96.
Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol. 2009; 144(1): 68-71.
Pirotta MV, Garland SM. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J Clin Microbiol. 2006; 44(9): 3213-7.
Tsega A, Mekonnen F. Prevalence, risk factors and antifungal susceptibility pattern of Candida species among pregnant women at Debre Markos Referral Hospital, Northwest Ethiopia. BMC Pregnancy Childbirth. 2019; 19(1): 527.
Marinho SA, Teixeira AB, Santos OS, Cazanova RF, Ferreira CA, Cherubini K, et al. Identification of Candida spp. by phenotypic tests and PCR. Braz J Microbiol. 2010; 41(2): 286-94.
Soll DR. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev. 2000; 13(2): 332-70.
Gupta V, Abhisheik K, Balasundari S, Devendra NK, Shadab K, Anupama M. Identification of Candida albicans using different culture media and its association in leukoplakia and oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2019; 23(1): 28-35.
Falahati M, Sharifinia S, Foroumadi AR, Bolouri F, Akhlagh L, Parast AY, et al. Drug Resistance Pattern in Candida Species Isolated from Vaginitis. Razi J Med Sci. 2009; 16(8): 40.
Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, Tavallaee M. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. Eur J Obstet Gynecol Reprod Biol. 2011; 155(2): 199-203.
Gharaghani M, Ahmadi B, Sisakht MT, Ilami O, Aramesh S, Mouhamadi F, et al. Identification of Candida species isolated from vulvovaginal candidiasis patients by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in Yasuj southwestern Iran. Jundishapur J Microbiol. 2018; 11(8): e65359.
Franco-Duarte R, Černáková L, Kadam S, Kaushik KS, Salehi B, Bevilacqua A, et al. Advances in Chemical and Biological Methods to Identify Microorganisms-From Past to Present. Microorganisms. 2019; 7(5): 130.
Ringdahl EN. Treatment of recurrent vulvovaginal candidiasis. Am Fam Physician. 2000; 61(11): 3306-12, 17.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Chronic Diseases Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
